Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • IR
    • IR News
    • Management
    • IR Library
    • Stock Information
    • Other Contents
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. 2021

2021

2021323

PR Heartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan

202131

PR Heartseed named "Minister of Science and Technology Policy Award"  at Japan Venture Awards 2021

2021128

Other Taiji Edogawa was appointed as External Audit & Supervisory Board Member

1 2

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
Seavans South Building 5F, 1-2-3 Shibaura, Minato-ku, Tokyo 105-0023, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • IR
  • Contacts

language

  • English
  • Japanese

GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED